In-Vitro Diagnostic Substance Manufacturing
This U.S. industry comprises establishments primarily engaged in manufacturing in-vitro (i.e., not taken internally) diagnostic substances, such as chemical, biological, or radioactive substances. It has no schema of its own: companies here are mapped on the Manufacturing schema, and what it does not cover is recorded as gaps.
- Baseline
- Manufacturing v2
- Inherited from
- Manufacturing
- Mapped on the schema
- 0 of 0 placed here
- Primitives
- 57 in 8 parts
- Last updated
- Nov 2, 2026
The numbers for this industry
United States · 2023 · NAICS 325413- Establishments
- 267
- Employees
- 45,459
- Annual payroll
- $5.2B
- Payroll per employee
- $115.4K
Establishments by number of employees
- 1-452
- 5-944
- 10-1928
- 1000+12
- 20-4941
- 50-9932
- 100-24929
- 250-49917
- 500-99912
Source: US Census Bureau, County Business Patterns 2023 (national file), employees as of mid-March 2023, payroll for the year; published 2025-06-26. Coded on NAICS 2017. Withheld cells read as not published.
Deepen this industry
Focused research on the organizations with the fewest mapped parts in in-vitro diagnostic substance manufacturing; what it finds is public for everyone.